Tell BrainStorm: The ALS Community Deserves Transparency
On January 11th, 2023, the FDA and BrainStorm met to discuss the contents of a refusal to file letter in response to BrainStorm’s new Biologics License Application (BLA) for NurOwn.
On January 12th, 2023, BrainStorm tweeted:
Months have passed. BrainStorm promised to share information about how the meeting went and what the next steps are. Information has not been shared.
The ALS community deserves to know.
We are asking BrainStorm to be transparent, as they said they would be. Use this form to send a pre-populated tweet that tags BrainStorm. Your tweet will read:
@BrainstormCell, you promised the #ALS community minutes from your #NurOwn meeting with the @US_FDA . You haven’t shared those minutes nor have you been transparent. The ALS community deserves better. We deserve transparency.
Once you submit the form, click the tweet button on the right:
